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Abstract: This study was carried out to investigate the effects of a low hypochlorite concentration as a cleaning substance on pulmonary functions. For this purpose, 23 cleaning workers from the Faculty of Medicine of
Suleyman Demirel University were selected as
the study group and 14 people from technical
personnel as the control group. The study
group consisted of 17 females and 6 males
with a mean age of 26.4±5.6 years and the
mean duration of exposure to the substance in
question was 10.3±10.7 months without any
atopy history. The control group consisted of
12 females and 2 males with a mean age of
24.4±5.4 years. There was no atopy history.
The total IgE level and the total blood
eosinophil count of the study group and those
of the control group were similar. Pulmonary
function tests were applied three times to all
the subjects on Monday morning, and Monday and Friday afternoon. In the study group,
16 subjects were symptomatic under the
working circumstances and the results of the
physical examination were positive in 5 out of
the symptomatic subjects. The baseline values
of FVC (%), FEV1 (%), FEV1/FVC (%),
FEF25-75 (%), PEFR (L/s), and PEFR (%)
were higher than those of the control group.

Department of Chest Diseases and Tuberculosis, Faculty of Medicine, Süleyman Demirel
University, Isparta - TURKEY

It was found that the decreases in the FEV1
(L), FEV1 (%), FEV1/FVC (%), PEFR (L/s),
and PEFR (%) values of pulmonary function
tests measured on Monday afternoon and the
decreases in all the test values except the FVC
value measured on Friday afternoon were statistically significant. There were no differences between the baseline values of pulmonary function tests except the FVC (L)
value of the symptomatic and the nonsymptomatic subjects. There were significant
decreases in the FEV1 (%), FEV1/FVC (%),
and PEFR (%) weekend values of the nonsymptomatic group. There were statistically
significant increases in the FEV1 (L) and
FEV1/FVC (%) weekend values of the control
group compared to the baseline values. There
were statistically significant decreases in the
FEV1 (L), FEV1 (%), FEV1/FVC (%), and
PEFR (%) weekend values of the study group
compared to those of the control group.
These results suggest that even a low concentration of hypochlorite can affect the pulmonary functions by causing irritation in the
airways.
Key Words: Hypochlorite, pulmonary functions

Introduction

Materials and Methods

Hypochlorite is widely used as a cleaning substance in
homes and work places in our society. During the use of
this substance, chlorine gas having an intermediate water
solubility is released. When inhaled in low concentrations,
chlorine gas can cause irritation, inflammation of the
mucosal cells in the upper respiratory tract and proximal
airways and exaggerated physiological responses. Inhaled
in high concentrations, it can cause interstitial pneumonia,
pulmonary edema, progressive respiratory failure, and
death by affecting the gas exchanging parts of the lungs
(1,2).

This study was carried out with 23 cleaning workers
(17 females, 6 males) from the Faculty of Medicine of
Suleyman Demirel University as the study group, and 14
people from the technical personnel (12 females, 2
males) of the Faculty as the control group in July 1998.

This study was conducted to investigate the effects of
a low hypochlorite concentration as a cleaning substance
on pulmonary functions.

All the subjects were asked to complete a questionnaire covering the information on upper respiratory
symptoms, respiratory symptoms, ocular symptoms,
smoking history, and family history of atopy. In addition
all of them underwent a thorough physical examination.
Blood samples were taken for the total IgE level and
the total blood eosinophil count. The total IgE level was
estimated by enzyme-linked immunosorbent assay
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(ELISA) (Abbott Diagnostic, USA), and the total blood
eosinophil count was measured by using a model STKS
Coulter Counter (Coulter Electronics, USA).

Windows, Chicago, IL) and a p value less than 0.05 was
assumed to be significant (4).

Pulmonary function tests were applied three times to
all the subjects on Monday morning, Monday afternoon
(4 p.m.) and Friday afternoon (4 p.m.) in the seated position using a dry spirometer (Spirometrics. Inc SMI III,
USA). The absolute and the predicted values of forced
vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/forced vital capacity ratio, forced expiratory flow from 25 to 75 percent of vital capacity
(FEF25-75), and peak expiratory flow rate (PEFR) parameters were determined. By using the American Thoracic
Society standards (3), at least three pulmonary function
tests were recorded for each subject, and the best value
was used as the result of the test.

Results

The study group was divided into subgroups according to symptoms and smoking habits. Ten subjects in the
study group had 5.9±5.2 pack-year and 5 subjects of the
control group had 3.5±3.1 pack-year smoking status.
Nine subjects in the symptomatic group had 5.6±5.5
pack-year and 1 subject of the nonsymptomatic group
had 7.5±0.0 pack-year smoking status.
In this study, the concentrations of hypochlorite and
chlorine were not measured because of the unavailability
of the laboratory. However, hypochlorite was used diluted with water.
The results were expressed as mean values±standard
error of mean (S.E.M.). The demographic and clinical
characteristics between the groups were assessed by the
independent samples t test. For statistical analysis of the
mean values of the pulmonary function tests (baseline,
Monday afternoon and Friday afternoon) in the study
group or the control group, the paired t test was used.
Comparisons of the mean values of the pulmonary function tests (baseline, Monday afternoon and Friday afternoon) between the study group and the control group or
the symptomatic subjects and the nonsymptomatic subjects or the smoking subjects and the nonsmoking subjects were made by the Mann-Whitney U test. The differences in the mean values of pulmonary function tests
(baseline, Monday afternoon and Friday afternoon) in the
symptomatic subjects or the nonsymptomatic subjects
and the smoking subjects or the nonsmoking subjects
were tested by the Wilcoxon test. Statistical analysis were
conducted by the SPSS statistical package (SPSS 9.0 for
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In the study group, the mean age was 26.4± 5.6
years, the mean duration of exposure to hypochlorite
10.3±10.7 months, the total serum IgE level 93.0±99.0
IU/ml, and the total blood eosinophil count 0.2±0.1 %.
In the control group, the mean age was 24.4±5.4 years,
the total serum IgE level 53.7±50.8 IU/ml, and the blood
eosinophil count 0.2±0.2 %.
There were no statistically significant differences
between the study group and the control group for the
total serum IgE level, the total blood eosinophil count,
and the smoking status.
Both the study group and the control group had no
history of atopy such as bronchial asthma, allergic rhinitis, or atopic dermatitis.
While the study group revealed some symptoms
developed in the working circumstances during the study,
the control group did not. As shown in Table 1, of the
23 cleaning workers interviewed, 16 (82.0 %) had the
working symptoms. Sixteen (100.0%) out of the symptomatic subjects had respiratory symptoms, 11 (68.8%)
had symptoms related to ear, nose and throat, 8(50.0%)
ocular symptoms, and 7 (43.8%) had headaches.

Table 1.

The distribution of the working symptoms among the study
group.

Symptoms

Subject
number

(%)

Symptoms

Subject
number

(%

25.0

Cough

5

31.3

Throat tickling

4

Dyspnea

5

31.3

Rhinorrhea

2

12.5

Wheeze

3

18.8

Sore throat

4

25.0

Chest tightness

3

18.8

Sneezing

1

6.3

Ocular symptoms

8

50.0

Headache

7

43.8

The baseline (Monday morning) values of pulmonary
function tests of the study group and the control group
are listed in Table 2. The results suggest that there
were statistically significant increases in the FVC (%),
FEV1 (%), FEV1/FVC (%), FEF25-75 (%), PEFR (L/s),
and PEFR (%) baseline values of the study group
(p<0.05).
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Table 2.

The baseline (Monday morning) values of pulmonary function tests of the study group and the control group.

Table 4.

Study group

Control group

p

FVC (L)

3.77±0.7

3.67±0.8

p>0.05

FVC (%)

106.2±13.2

96.2±11.4

p<0.05

FVC (L)
FVC (%)

FEV1 (L)

2.90±0.7

2.53±0.9

p>0.05

FEV1 (%)

94.2±17.4

75.6±16.3

p<0.05

FEV1/FVC (%)

88.3±14.1

78.5±16.9

p<0.05

FEF25-75 (L/s)

2.84±1.0

2.50±1.4

p>0.05

FEF25-75 (%)

76.7±23.4

62.1±25.5

p<0.05

3.67±2.8

p<0.05

47.0±26.9

p<0.05

PEFR (L/s)

4.23±1.7

PEFR (%)

57.3±18.0

The values of pulmonary function tests of the study group
on Monday morning and Friday afternoon.
Study group
Monday morning

Study group
Friday afternoon

p

3.77±0.7

3.64±0.6

p>0.05

106.2±13.2

102.8±11.5

p>0.05

FEV1 (L)

2.90±0.7

2.33±0.8

p<0.01

FEV1 (%)

94.2±17.4

72.0±21.4

p<0.001

FEV1/FVC (%)

88.3±14.1

70.8±20.3

p<0.001

FEF25-75 (L/s)

2.84±1.0

2.19±1.1

p<0.05

FEF25-75 (%)

76.7±23.4

59.9±26.8

p<0.01

PEFR (L/s)

4.23±1.7

3.23±1.7

p<0.05

PEFR (%)

57.3±18.0

44.4±22.6

p<0.05

The values of pulmonary function tests of the study
group measured on Monday morning and Monday afternoon show statistically significant decreases in the FEV1
(L), FEV1 (%), FEV1/FVC (%), PEFR (L/s), and PEFR (%)
values on Monday afternoon compared to those in the
baseline values (p<0.05) (Table 3).

The values of pulmonary function tests of the study
group and the control group measured on Monday afternoon are listed in Table 5. It is evident that there was a
statistically significant decrease in the FEV1 (L) value of
the study group compared to that of the control group
(p<0.05).

Table 3.

Table 5.

The values of pulmonary function tests of the study group
on Monday morning and Monday afternoon.
Study group
Monday morning

Study group
Monday afternoon

p

FVC (L)

3.77±0.7

3.45±0.6

p>0.05

FVC (%)

106.2±13.2

100.9±14.9

p>0.05

The values of pulmonary function tests of the study group
and the control group on Monday afternoon.
Study group
Monday afternoon

Control group
Monday afternoon

p

FVC (L)

3.45±0.6

3.77±0.7

p>0.05

FVC (%)

100.9±14.9

96.4±9.5

p>0.05

2.41±0.7

2.88±0.7

p<0.05

FEV1 (L)

2.90±0.7

2.41±0.7

p<0.05

FEV1 (L)

FEV1 (%)

94.2±17.4

80.7±20.6

p<0.05

FEV1 (%)

80.7±20.6

84.2±12.2

p>0.05

FEV1/FVC (%)

79.7±18.2

88.2±15.1

p>0.05

FEV1/FVC (%)

88.3±14.1

79.7±18.2

p<0.05

FEF25-75 (L/s)

2.84±1.0

2.36±1.1

p>0.05

FEF25-75 (%)

76.7±23.4

64.9±27.6

p>0.05

PEFR (L/s)

4.23±1.7

3.47±1.8

p<0.05

PEFR (%)

57.3±18.0

49.9±19.9

p<0.05

The values of pulmonary function tests of the study
group measured on Monday morning and Friday afternoon reveal statistically significant decreases in all the test
values except the FVC value on Friday afternoon (p<0.05,
p<0.01, p<0.001) (Table 4).

FEF25-75 (L/s)

2.36±1.1

2.88±1.2

p>0.05

FEF25-75 (%)

64.9±27.6

70.4±19.5

p>0.05

PEFR (L/s)

3.47±1.8

3.77±1.6

p>0.05

PEFR (%)

49.9±19.9

48.2±14.6

p>0.05

The values of pulmonary function tests of the study
group and the control group measured on Friday afternoon are listed in Table 6. We can see that there were
statistically significant decreases in the FEV1 (L), FEV1
(%), FEV1/FVC (%), and PEFR (%) weekend values of
the study group compared to those of the control group
(p<0.05). Although the FVC (%) value proved to be
lower in the control group, it was within normal limits.
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Table 6.

The values of pulmonary function tests of the study group
and the control group on Friday afternoon.

FVC (L)
FVC (%)
FEV1 (L)
FEV1 (%)
FEV1/FVC (%)
FEF25-75 (L/s)
FEF25-75 (%)
PEFR (L/s)
PEFR (%)

Study group
Friday afternoon

Control group
Friday afternoon

p

3.64±0.6
102.8±11.5
2.33±0.8
72.0±21.4
70.8±20.3
2.19±1.1
59.9±26.8
3.23±1.7
44.4±22.6

3.67±0.8
95.0±8.2
2.86±0.7
84.3±11.9
89.0±16.1
2.88±1.2
72.4±22.4
4.50±20.9
56.8±16.2

p>0.05
p<0.05
p<0.05
p<0.05
p<0.05
p>0.05
p>0.05
p>0.05
p<0.05

The values of pulmonary function tests of the control
group measured on Monday morning and Friday afternoon
confirm that there were statistically significant increases in
the FEV1 (L), FEV1/FVC (%) weekend values compared to
those in the baseline values (p<0.05) (Table 7).
Table 7.

cant differences between the baseline values except the
FVC (L) value of the symptomatic and the nonsymptomatic subjects. Although it was found that the FVC (L)
value was higher in the nonsymptomatic subjects, it was
within normal limits.
Table 8.

FVC (L)
FVC (%)
FEV1 (L)
FEV1 (%)
FEV1/FVC (%)
FEF25-75 (L/s)
FEF25-75 (%)
PEFR (L/s)
PEFR (%)

Study group
(symptomatic)
Monday morning

Study group
(nonsymptomatic)
Monday morning

p

3.58±0.5
104.1±12.4
2.88±0.6
95.5±16.3
91.6±11.5
2.93±1.0
80.8±24.9
4.32±1.7
60.9±17.6

4.21±0.7
111.0±14.7
2.95±0.8
89.7±20.7
80.7±17.5
2.63±0.9
67.3±17.8
4.03±1.9
49.9±18.0

p<0.05
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05

The values of pulmonary function tests of the control group
on Monday morning and Friday afternoon.

FVC (L)
FVC (%)
FEV1 (L)
FEV1 (%)
FEV1/FVC (%)
FEF25-75 (L/s)
FEF25-75 (%)
PEFR (L/s)
PEFR (%)

Control group
Monday morning

Control group
Friday afternoon

p

3.67±0.8
96.2±11.4
2.53±0.9
75.6±16.3
78.5±16.9
2.50±1.4
62.1±25.5
3.67±2.8
47.0±26.9

3.67±0.8
95.0±8.2
2.86±0.7
84.3±11.9
89.0±16.1
2.88±1.2
72.4±22.4
4.50±20.9
56.8±16.2

p>0.05
p>0.05
p<0.05
p>0.05
p<0.05
p>0.05
p>0.05
p>0.05
p>0.05

There were no statistically significant differences
between the values of pulmonary function tests of the
symptomatic subjects in the study group measured on
Monday morning and Monday afternoon.
The values of pulmonary function tests of the symptomatic subjects in the study group measured on Monday
morning and Friday afternoon illustrate statistically significant decreases in the FEV1 (L), FEV1 (%), and
FEV1/FVC (%) weekend values compared to those in the
baseline values (p<0.05) (Table 9).
Table 9.

In the symptomatic subjects of the study group the
total IgE level was 100.8±10.5 IU/ml and the total blood
eosinophil count was 0.2±0.2%. In the nonsymptomatic
subjects of the study group the total serum IgE level was
74.9± 89.2 IU/ml and the total blood eosinophil count
was 0.2±0.1%. There were no statistically significant differences between the symptomatic subjects and the nonsymptomatic subjects for the total IgE level, the total
blood eosinophil count, and smoking status.
The baseline values of pulmonary function tests of the
symptomatic and the nonsymptomatic subjects in the
study group are listed in Table 8. There were nonsignifi-
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The baseline values of pulmonary function tests of the
symptomatic and the nonsymptomatic subjects in the study
group.

The values of pulmonary function tests of the symptomatic
subjects on Monday morning and Friday afternoon.

FVC (L)
FVC (%)
FEV1 (L)
FEV1 (%)
FEV1/FVC (%)
FEF25-75 (L/s)
FEF25-75 (%)
PEFR (L/s)
PEFR (%)

Study group
(symptomatic)
Monday morning

Study group
(symptomatic)
Friday afternoon

p

3.58±0.5
104.1±12.4
2.88±0.6
95.5±16.3
91.6±11.5
2.93±1.0
80.8±24.9
4.32±1.7
60.9±17.6

3.48±0.5
101.9±12.4
2.40±0.8
78.4±21.4
77.4±18.8
2.43±1.2
67.4±28.9
3.75±1.9
53.7±22.1

p>0.05
p>0.05
p<0.05
p<0.05
p<0.05
p>0.05
p>0.05
p>0.05
p>0.05

R. DEM‹RALAY

The values of pulmonary function tests of the symptomatic and the nonsymptomatic subjects measured on
Monday afternoon are listed in Table 10. The decreases
in the FEV1 (L), FEV1 (%), FEV1/FVC (%), FEF25-75
(L/s), FEF25-75 (%), PEFR (L/s), and PEFR (%) values of
the nonsymptomatic subjects were statistically significant
(p<0.05).

Table 10.

The values of pulmonary function tests of the symptomatic
and the nonsymptomatic subjects on Monday afternoon.

FVC (L)
FVC (%)
FEV1 (L)
FEV1 (%)
FEV1/FVC (%)
FEF25-75 (L/s)
FEF25-75 (%)
PEFR (L/s)
PEFR (%)

Study group
(symptomatic)
Monday afternoon

Study group
(nonsymptomatic)
Monday afternoon

p

3.38±0.6
99.4±16.3
2.59±0.7
88.3±19.2
86.5±13.9
2.63±1.2
72.6±28.6
3.95±1.9
58.2±18.3

3.67±0.5
105.4±10.9
1.90±0.5
62.3±15.2
59.1±16.2
1.54±0.5
41.9±12.3
2.00±0.7
24.7±7.5

p>0.05
p>0.05
p<0.05
p<0.05
p<0.05
p<0.05
p<0.05
p<0.05
p<0.05

The values of pulmonary function tests of the symptomatic and the nonsymptomatic subjects measured on
Friday afternoon reveal statistically significant decreases
in the FEV1 (%), FEV1/FVC (%),and PEFR (%) weekend
values of the nonsymptomatic subjects (p<0.05) (Table
11).

Table 11.

The values of pulmonary function tests of the symptomatic
and the nonsymptomatic subjects on Friday afternoon.

FVC (L)
FVC (%)
FEV1 (L)
FEV1 (%)
FEV1/FVC (%)
FEF25-75 (L/s)
FEF25-75 (%)
PEFR (L/s)
PEFR (%)

Study group
(symptomatic)
Friday afternoon

Study group
(nonsymptomatic)
Friday afternoon

p

3.48±0.5
101.9±12.4
2.40±0.8
78.4±21.4
77.4±18.8
2.43±1.2
67.4±28.9
3.75±1.9
53.7±22.1

4.02±0.8
104.5±10.1
1.89±0.5
58.1±15.5
56.3±19.0
1.64±0.5
43.3±11.8
2.02±0.5
26.1±8.7

p>0.05
p>0.05
p>0.05
p<0.05
p<0.05
p>0.05
p>0.05
p>0.05
p<0.05

The results of the physical examination made on Friday afternoon were positive (rhonchus) in 5 of the symptomatic subjects.
There were nonsignificant differences between the
smokers and the nonsmokers in the study group for the
total serum IgE level and the total blood eosinophil count.
The FEV1 (L), FEV1/FVC (%), FEF25-75 (L/s), FEF2575 (%), PEFR (L/s), and PEFR (%) baseline values of
pulmonary function tests were lower in the nonsmokers.
There were statistically significant decreases in the FEV1
(L), FEF25-75 (L/s), and PEFR (L/s) weekend values of
pulmonary function tests of the nonsmokers compared to
those of the smokers. No statistically significant differences were found between the values of pulmonary function tests of the smokers measured on Monday morning
and Friday afternoon.

Discussion
Chlorine gas, which is released during the use of
hypochlorite, leads to the formation of hydrochlorite acid
and free oxygen radicals by reacting with water in the
mucous membranes. Chlorine gas, the hydrochlorite acid
and the free oxygen radicals can cause mucous membrane
irritation, bronchospasm, pneumonia, and pulmonary
edema (5,6).
Hypochlorite (diluted 1:10) includes 5.0 ppm free
chlorine (7). The pungent odor of chlorine is even detected in concentrations as low as 0.5 ppm, but chlorine causes respiratory damage only at levels above 20.0 ppm (8).
According to the guide of the National Institute of Occupational Safety and Health, the recommended 8-hour
occupational permissible exposure level for chlorine is 0.5
ppm and the recommended occupational 15-minute ceiling short-term exposure limit for chlorine is 1.0 ppm (9).
The acute inhalation in toxic concentrations of the respiratory irritants such as hypochlorite and chlorine gas
results in a clinical entity described as reactive airways
dysfunction syndrome (RADS) (10,11). It is generally
believed that exposure to nontoxic levels of irritant gases
does not lead to impaired pulmonary function, although
little is known of the long-term consequences of an acute
high-level or chronic exposure to these substances
(10,12). Recently, it has been thought that repeated
exposure to the irritant inhalation in tolerable concentrations can also cause RADS (10,11).
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Reactive airways dysfunction syndrome is a clinical
pathologic entity characterized by exposure to a toxic or
irritant chemical, a negative history of obstructive symptoms prior to exposure, persistence of obstructive symptoms after exposure, objective evidence of obstructive
airways disease and/or nonspesific bronchial hyperresponsiveness, and abnormal bronchial biopsy results
(10,11). It differs from hypersensivity-induced occupational asthma because of the absence of a preceding latent
period and the onset of the illness after a single exposure
(1,11).
In this study, 82.0% of the study group developed
different symptoms related to the lungs, ear-nose-throat,
and eyes which diminished or disappeared outside work.
These symptoms are thought to occur as a result of the
direct irritant effect of hypochlorite. Irritants deposited
or dissolved in the upper respiratory tract and proximal
airways may cause injury to airway mucosal cells, exaggerated physiological responses, an acute inflammatory
reaction, or all three of these. Exaggerated physiological
responses include coughing as a result of stimulation of
afferent nerve endings in the airway mucosa, mucus
secretion of submucosal and goblet cells, and acute airway narrowing (1,13).
The following findings suggest that there were
obstructive signs in the hypochlorite exposed group compared to the control group: a) the baseline values of pulmonary function tests of the study group and the control
group were in normal limits (Table 2); b) there were significant decreases in the weekend values of pulmonary
function tests especially in the FEV1 (L), FEV1 (%), and
FEV1/FVC (%) values of the study group compared to
those of the baseline values (Table 4); c) there were significant decreases in the FEV1 (L), FEV1 (%), FEV1/FVC
(%), and PEFR (%) weekend values of pulmonary function tests of the study group compared to those of the
control group (Table 6); d) there were significant increases in the weekend values of pulmonary function tests of
the control group compared to the baseline values (Table
7). In addition, it was found that there were significant
decreases in the values of pulmonary function tests measured on Friday afternoon of the symptomatic and nonsymptomatic subjects in the study group compared to the
baseline values and the obstructive influence was higher
in the nonsymptomatic subjects than that in the symptomatic subjects. Controlled human exposure data suggest
that respiratory symptoms following irritant exposure are
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associated with smoking and asthma and typically resolve
quickly, and continuing symptoms are associated with
persistent increased airway responsiveness without other
pulmonary function abnormalities (14,15 ).
There were significant decreases in the baseline and
the weekend values of pulmonary function tests of the
nonsmokers compared to those of the smokers, and also
nonsignificant differences in the weekend values of pulmonary function tests of the smokers compared to the
baseline values show that smoking is not a risk factor. As
a matter of fact, it is reported that smoking is a predisposing factor to the development of IgE-mediated occupational asthma, and it increases sensitiveness against the
exposed agent and is not effectual in the irritant-induced
asthma (16).
There is only limited controlled human chlorine exposure data. In a relevant controlled human chlorine exposure study in which eight healthy volunteers were
exposed to chlorine in concentrations of 0.5 ppm or 1.0
ppm, there were unimportant changes observed with the
0.5 ppm exposure, and with the 1.0 ppm exposure,
there was a decrease in airflow and an increase in airway
resistance. In addition, there were significant changes
after only 4-hour-exposure and most of the test results
had returned to normal by the next day (17). In another
study in which airway responses to chlorine inhalation
(0.4 or 1.0 ppm concentrations) among subjects with
nonspecific airway hyperreactivity were directly examined, there was an acute, short-term fall in airflow and
an increase in airway resistance in both normal subjects
and subjects with increased nonspecific airway reactivity
after 1.0 ppm chlorine inhalation and a significantly
greater response among the hyperresponsiveness group
as compared with normal subjects. At 24-hour follow-up
there were nonsignificant chlorine-related pulmonary
function deficits and, in addition, after 0.4 ppm chlorine
inhalation, there was also a nonsignificant pulmonary
function effect (9).
Persistent asthma is reported to occur after the
inhalation of the irritant in high concentrations (5). It is
thought that the symptoms continuing for years are associated with persistent bronchial hyperreactivity without
other pulmonary function abnormalities (15,18).
In conclusion, hypochlorite, even used in low concentrations, can lead to clinical and functional defects by
causing irritation in the airways.

R. DEM‹RALAY
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